Where does Heart Repair Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Heart Repair Technologies, Inc. ranks #18,708 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Heart Repair Technologies, Inc. hold?

Heart Repair Technologies, Inc. holds 15 US utility patents granted between 2015 and 2025, spanning 3 technology areas.

What is Heart Repair Technologies, Inc.'s Innovation Score?

Heart Repair Technologies, Inc. has an Innovation Score of 27.6 out of 100 (24th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Heart Repair Technologies, Inc.'s patent grant rate increasing or decreasing?

Heart Repair Technologies, Inc.'s recent grant velocity is -56% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Heart Repair Technologies, Inc.'s patents?

Heart Repair Technologies, Inc.'s patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Heart Repair Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Heart Repair Technologies, Inc.

Q: What technology areas does Heart Repair Technologies, Inc. focus on?

Heart Repair Technologies, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 15 patents, ranking #428 of 3,082 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 15 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Heart ranks #18,708 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 3 technology areas.

#18,708
of 49,997 US assignees by volume: 24th percentile
by Innovation Score (27.6/100): 18.1
avg claims per patent: -56%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18708 · US Corporation #18,708 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,708/49,997
PHOTO-FINISH Handy & Harman
CPC-NARROW A61F · 3 areas
INNOV-THIN 27.6/100
CLAIMS-RICH 18.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -56% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Handy & Harman (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Heart’s 27.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (35%) Velocity 1.1 pts (4%) Breadth 6.1 pts (22%) Claim depth 10.8 pts (39%)

Qualcomm Incorporated · highest

85
Heart Repair · this assignee

28
3D Lighting… · lowest

7

What this shows Heart's Innovation Score is 27.6/100 (24th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Heart?

Each dot is one of Heart’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Heart’s own 18.1 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Heart vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Heart's grants concentrate

Heart Repair Technologies, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2016. By volume, Heart sits between Handy & Harman and Henan University.

Heart's three-year grant acceleration

Heart Repair Technologies, Inc. shows 1 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Handy & Harman

15
Hangzhou Hikvisio…

15
Hans Heidolph

15
Hawkeye 360

15
Heat Biologics

15
Hecktech

15
Henan Polytechnic…

15
Henan University

15
Heart Repair ◀

15

What this shows Heart holds 15 patents at rank #18,719, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Heart

By rank, the assignees closest to #18,719 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Heart's primary technology class.

Heart's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 24th percentile higher than 24% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Heart Repair Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	20.0%
2016	1	6.7%
2017	2	13.3%
2019	3	20.0%
2021	3	20.0%
2024	1	6.7%
2025partial year	2	13.3%

Which technologies does Heart Repair Technologies, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 15

A61B - DIAGNOSIS; SURGERY; Identification 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Heart Repair Technologies, Inc.'s patent record in context - here's where to go next.

Heart Repair Technologies, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #18,708 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Heart Repair Technologies, Inc. against Handy & Harman, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.